PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

Rui Wang; Lei Xi; Rakesh C. Kukreja

doi:10.1124/jpet.116.239087

Research ArticleCardiovascular

PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

Rui Wang, Lei Xi and Rakesh C. Kukreja

Journal of Pharmacology and Experimental Therapeutics April 2017, 361 (1) 29-38; DOI: https://doi.org/10.1124/jpet.116.239087

Rui Wang

Pauley Heart Center, Division of Cardiology, Virginia Commonwealth University. Richmond, Virginia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lei Xi

Pauley Heart Center, Division of Cardiology, Virginia Commonwealth University. Richmond, Virginia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rakesh C. Kukreja

Pauley Heart Center, Division of Cardiology, Virginia Commonwealth University. Richmond, Virginia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$25.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 361, Issue 1

1 Apr 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

Citation Tools

Research ArticleCardiovascular

Tadalafil and Hydroxychloroquine Protect Diabetic Heart

Rui Wang, Lei Xi and Rakesh C. Kukreja

Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 29-38; DOI: https://doi.org/10.1124/jpet.116.239087

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleCardiovascular

Tadalafil and Hydroxychloroquine Protect Diabetic Heart

Rui Wang, Lei Xi and Rakesh C. Kukreja

Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 29-38; DOI: https://doi.org/10.1124/jpet.116.239087

Permalink:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice

In this issue

Tadalafil and Hydroxychloroquine Protect Diabetic Heart

Citation Manager Formats

Tadalafil and Hydroxychloroquine Protect Diabetic Heart

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals